Zhigang C. Wang

7.4k citations

22 papers · 3.9k indexed · 3 hit papers · h-index 16

Molecular Biology top 2%
Oncology top 1%
Cancer Research top 1%
Genetics top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: J. Dirk Iglehart Andrea L. Richardson Alexander Miron Xin Lü Arcangela De Nicolo Myles Brown Shridar Ganesan David M. Livingston
Topics: BRCA gene mutations in cancer (6 papers)Cancer Genomics and Diagnostics (6 papers)DNA Repair Mechanisms (5 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nature Medicine
Partner nations: United States Denmark United Kingdom

In The Last Decade

Zhigang C. Wang

21 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

X chromosomal abnormalities in basal-like human breast cancer

2006 668 citations Andrea L. Richardson, Zhigang C. Wang et al. Cancer Cell profile →
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

2010 659 citations Yasushi Kojima, Ahmet Acar et al. Proceedings of the National Academy of Sciences profile →
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer

2015 347 citations Yubao Wang, Tinghu Zhang et al. Cell profile →

Peers

Countries citing papers authored by Zhigang C. Wang

Since Specialization

Citations

This map shows the geographic impact of Zhigang C. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang C. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang C. Wang more than expected).

Fields of papers citing papers by Zhigang C. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigang C. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang C. Wang. The network helps show where Zhigang C. Wang may publish in the future.

Co-authorship network of co-authors of Zhigang C. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhigang C. Wang. A scholar is included among the top collaborators of Zhigang C. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigang C. Wang. Zhigang C. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition 2019 ·Clinical Cancer Research ·Kalindi Parmar,Bose Kochupurakkal,Jean‐Bernard Lazaro,Zhigang C. Wang,Sangeetha Palakurthi,Paul T. Kirschmeier,Chunyu Yang,Larissa A. Sambel,Anniina Färkkilä,Elizaveta Reznichenko,Hunter D. Reavis,Connor E. Dunn,Lee Zou,T. Khanh,Panagiotis A. Konstantinopoulos,Ursula A. Matulonis,Joyce F. Liu,Alan D. D’Andrea,Geoffrey I. Shapiro	103
2	RelA-Induced Interferon Response Negatively Regulates Proliferation 2015 ·PLoS ONE ·Bose Kochupurakkal,Zhigang C. Wang,(unknown),Aedín C. Culhane,Scott J. Rodig,(unknown),(unknown),Andrea L. Richardson,Debajit K. Biswas,J. Dirk Iglehart	18
3	CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancerbreakdown → 2015 ·Cell ·Yubao Wang,Tinghu Zhang,Nicholas Kwiatkowski,Brian J. Abraham,Tong Ihn Lee,Shaozhen Xie,Haluk Yuzugullu,Thanh Von,Heyuan Li,Ziao Lin,Daniel G. Stover,Elgene Lim,Zhigang C. Wang,J. Dirk Iglehart,Richard A. Young,Nathanael S. Gray,Jean J. Zhao	347
4	Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs 2015 ·Biomarker Research ·Andrea Marion Marquard,Aron C. Eklund,Tejal Joshi,Marcin Krzystanek,Francesco Favero,Zhigang C. Wang,Andrea L. Richardson,Daniel P. Silver,Zoltán Szállási,Nicolai J. Birkbak	180
5	Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations 2013 ·PLoS ONE ·Nicolai J. Birkbak,Bose Kochupurakkal,José M. G. Izarzugaza,Aron C. Eklund,Yang Li,Joyce F. Liu,Zoltán Szállási,Ursula A. Matulonis,Andrea L. Richardson,J. Dirk Iglehart,Zhigang C. Wang	105
6	Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents 2012 ·Cancer Discovery ·Nicolai J. Birkbak,Zhigang C. Wang,Ji-Young Kim,Aron C. Eklund,Qiyuan Li,Ruiyang Tian,Christian Bowman-Colin,Yang Li,April Greene-Colozzi,J. Dirk Iglehart,Nadine Tung,Paula D. Ryan,Judy E. Garber,Daniel P. Silver,Zoltán Szállási,Andrea L. Richardson	412
7	The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis 2012 ·Genes & Development ·Tamara Utermark,(unknown),Hailing Cheng,Qi Wang,Sang‐Hyun Lee,Zhigang C. Wang,J. Dirk Iglehart,Thomas M. Roberts,William J. Muller,Jean J. Zhao	112
8	Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsbreakdown → 2010 ·Proceedings of the National Academy of Sciences ·Yasushi Kojima,Ahmet Acar,Elinor Ng Eaton,Kieran T. Mellody,Christina Scheel,Ittai Ben‐Porath,Tamer T. Önder,Zhigang C. Wang,Andrea L. Richardson,Robert A. Weinberg,Akira Orimo	659
9	High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays 2009 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),Li Zhang,Martin Moorhead,Zhigang C. Wang,(unknown),(unknown),(unknown),(unknown),(unknown),Ralf Krahe,Musaffe Tuna,Patricia A. Thompson,Paul T. Spellman,Joe W. Gray,Gordon B. Mills,Malek Faham	79
10	Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling 2009 ·Cancer Cell ·Christina Gewinner,Zhigang C. Wang,Andrea L. Richardson,Julie Teruya‐Feldstein,Dariush Etemadmoghadam,David D.L. Bowtell,Jordi Barretina,William M. Lin,Lucia E. Rameh,Leonardo Salmena,Pier Paolo Pandolfi,Lewis C. Cantley	365
11	SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis 2009 ·Science Signaling ·Hailing Cheng,Pixu Liu,Zhigang C. Wang,Lihua Zou,Stephanie Santiago,Victoria M. Garbitt,Ole Gjoerup,J. Dirk Iglehart,Alexander Miron,Andrea L. Richardson,William C. Hahn,Jean J. Zhao	131
12	Predicting features of breast cancer with gene expression patterns 2007 ·Breast Cancer Research and Treatment ·Xuesong Lu,Xin Lü,Zhigang C. Wang,J. Dirk Iglehart,Xuegong Zhang,Andrea L. Richardson	188
13	Amplification of chromosome 8q22 and metastasis of breast cancers 2006 ·Cancer Research ·Zhigang C. Wang,Yan Li,J. Dirk Iglehart,Andrea L. Richardson	2
14	X chromosomal abnormalities in basal-like human breast cancerbreakdown → 2006 ·Cancer Cell ·Andrea L. Richardson,Zhigang C. Wang,Arcangela De Nicolo,Xin Lü,Myles Brown,Alexander Miron,Xiaodong Liao,J. Dirk Iglehart,David M. Livingston,Shridar Ganesan	668
15	A role for the scaffolding adapter GAB2 in breast cancer 2005 ·Nature Medicine ·Mohamed Bentires‐Alj,Susana G. Gil,Richard Chan,Zhigang C. Wang,Yongping Wang,Naoko Imanaka,Lyndsay N. Harris,Andrea L. Richardson,Benjamin G. Neel,Haihua Gu	159
16	Maternal CD46H2 and IL1B-5111 homozygosity in T helper 1-type immunity to trophoblast antigens in recurrent pregnancy loss 2005 ·Human Reproduction ·Zhigang C. Wang,Joseph A. Hill,Edmond J. Yunis,Ling Xiao,Deborah J. Anderson	15
17	BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles 2005 ·Breast Cancer Research and Treatment ·Evan Matros,Zhigang C. Wang,(unknown),Alexander Miron,J. Dirk Iglehart,Andrea L. Richardson	143
18	Genomic approaches in cancer biology 2004 ·Surgery ·Evan Matros,Zhigang C. Wang,Andrea L. Richardson,J. Dirk Iglehart	2
19	Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers 2004 ·Cancer Research ·Zhigang C. Wang,Ming Gang Lin,L. J. Wei,Cheng Li,Alexander Miron,(unknown),Lyndsay Harris,Sridhar Ramaswamy,David M. Tanenbaum,Matthew Meyerson,J. Dirk Iglehart,Andrea Richardson	150
20	Molecular characterization of the HLA-Cw∗0409N allele 2002 ·Human Immunology ·Zhigang C. Wang,Anajane G. Smith,Edmond J. Yunis,Annamalai Selvakumar,Soldano Ferrone,Susan McKinney,(unknown),Marcelo Fernández-Viña,John A. Hansen	11

About Zhigang C. Wang

Zhigang C. Wang is a scholar working on Cancer Research, Oncology and Genetics, having authored 22 papers that have together received 3.9k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (6 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.9k citations) and Molecular Biology (2.6k citations). Zhigang C. Wang has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include J. Dirk Iglehart, Andrea L. Richardson, Andrea L. Richardson, Alexander Miron, Xin Lü, Arcangela De Nicolo, Myles Brown, Shridar Ganesan, David M. Livingston and Xiaodong Liao. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact